|
UMIN-CTR History |
|
 UMIN-CTR English Home |
Glossary (Simple) |
FAQ |
Search clinical trials |
| Name: | UMIN ID: |
| Unique ID issued by UMIN | UMIN000004458 |
| Receipt No. | R000005337 |
| Scientific Title | Phase III trial evaluating the role of continuous letrozole versus intermittent letrozole following 4 to 6 years of prior adjuvant endocrine therapy for postmenopausal women with hormone-receptor positive, node positive early stage breast cancer |
| Date of disclosure of the study information | 2010/11/01 |
| Last modified on | 2018/08/24 10:05:09 |
| No. | Disposal | Last modified on | Item of update | |
| 1 | Insert | 2010/10/27 14:19:07 | ||
| 2 | Update | 2012/05/02 10:44:38 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2012/09/12 15:52:33 | Recruitment status |
|
| 4 | Update | 2013/10/29 13:21:38 | Email Institutions |
|
| 5 | Update | 2013/10/29 13:36:00 | Institutions |
|
| 6 | Update | 2014/10/30 13:55:36 | Address Address TEL Address Address TEL |
|
| 7 | Update | 2014/10/30 13:59:17 | Key inclusion criteria |
|
| 8 | Update | 2016/05/09 09:17:57 | Name of primary sponsor Organization |
|
| 9 | Update | 2018/08/17 10:29:22 | Acronym Acronym |
|
| 10 | Update | 2018/08/23 17:39:21 | Public title |
|
| 11 | Update | 2018/08/24 10:05:09 | UMIN ID1 |
